Oct 24 (Reuters) - The U.S. Centers for Disease Control and Prevention on Wednesday recommended expanding the use of vaccines to adults between 50-64 years to protect against pneumococcal disease.
The agency's earlier recommendation for vaccination was for adults 65 years or older and children younger than 5, as well as for children and adults with certain conditions.
Maternal COVID-19 infection during pregnancy may adversely affect the development of the newborn's heart, resulting in congenital heart defects (CHD), researchers suggested yesterday in Scientific Reports.
While they may not be a perfect match, the latest variants have enough in common with the KP.2 and JN.1 that the boosters should still offer effective cross-protection.
KIBATI, Democratic Republic of Congo, Oct 18 (Reuters) - Congo needs to do more to raise awareness about mpox and the availability of vaccines, an official with the response team said on Thursday, warning the campaign to distribute the shots would take longer than anticipated
Congo's mpox vaccination campaign launched this month in the hard-hit east.
